
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+9
Ajinomoto Cambrooke, Inc. formerly Cambrooke Therapeutics, Inc. (expansion of Cambrooke Foods) was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a rare disease called phenylketonuria (PKU). PKU is one of the few genetic diseases, which is managed almost entirely with nutritional intervention. The Paolellas goal in forming Cambrooke was simple - to develop improved nutritional therapeutic options for those with serious medical disorders. Today, Cambrooke produces medical formulas and foods for the management of a variety of medical conditions and we are continually innovating new nutritional options targeted at a wide array of...
Medical foods,nutritional theraphy,metabolic formula,low protein foods,protein supplement,glycomacropeptide,glytactin containing gmp,inborn errors of metabolism,ketogenic therapies,protein allergy,gi,medical formula,cystic fibrosis,and intractable epilesy
Ajinomoto cambrooke, inc operates in the Pharmaceutical manufacturing industry.
Ajinomoto cambrooke, inc's revenue is 11m - 100m
Ajinomoto cambrooke, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.